Invivyd (IVVD) just unveiled an announcement.
Invivyd, Inc. has announced the departure of Chief Executive Officer and Director David Hering, effective April 11, 2024, and is actively seeking his successor. Meanwhile, Jeremy Gowler has been appointed as the Interim CEO, while retaining his roles as COO and CCO. Gowler brings extensive industry experience from his time at Novartis, PaxVax, and Emergent Biosolutions, and will receive additional compensation during his interim tenure. The board has also been resized from nine to eight members, indicating a strategic adjustment in governance.
Find detailed analytics on IVVD stock on TipRanks’ Stock Analysis page.
